In this model, knocking out AMPK-α1 reduced recovery of T-ALL cells in spleen, lymph nodes, and bone marrow and enhanced mouse survival (Kishton et al., 2016). This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.